Animal models with a high predictive value for human trials are needed to develop novel
human-specific therapeutics for respiratory diseases. The aim of the present study was to examine
lung-function parameters in marmoset monkeys (Callithrix jacchus) that can be used
to detect pharmacologically or provocation-induced AHR (airway hyper-responsiveness). Therefore a
custom-made lung-function device that allows application of defined aerosol doses during measurement
was developed. It was hypothesized that LPS (lipopolysaccharide)-challenged marmosets show AHR
compared with non-challenged healthy subjects. Invasive plethysmography was performed in 12
anaesthetized orotracheally intubated and spontaneously breathing marmosets. Pulmonary data of
RL (lung resistance), Cdyn (dynamic
compliance), EF50 (mid-expiratory flow), Poes (oesophageal
pressure), MV (minute volume), respiratory frequency (f) and
VT (tidal volume) were collected. Measurements were conducted under
baseline conditions and under MCh (methacholine)-induced bronchoconstriction. The measurement was
repeated with the same group of animals after induction of an acute lung inflammation by
intratracheal application of LPS. PDs (provocative doses) of MCh to achieve a certain increase in
RL were significantly lower after LPS administration. AHR was
demonstrated in the LPS treated compared with the naïve animals. The recorded lung-function
data provide ground for pre-clinical efficacy and safety testing of anti-inflammatory substances in
the common marmoset, a new translational NHP (non-human primate) model for LPS-induced lung
inflammation.